When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DCPH - Deciphera Pharmaceuticals: Updates To Thesis Further Upside Ahead Post Phase 3 Win
Deciphera Pharmaceuticals Inc.
Shares of Deciphera Pharmaceuticals (DCPH) have risen by just 1% since my September 2018 article suggested initiating a pilot position in the near term and accumulating weakness. To be fair, I had thought ESMO data for DCC-2618 would boost shares and instead they lost nearly half their value due to falling ORR (objective response rate).
Recently, well known ROTY member Biotech Phoenix submitted this one to Idea Lab, stating that pivotal data in 4th Line GIST was compelling with efficacy as good or better than approved therapies in the 2nd/3rd line setting. He also notes